Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eleven analysts that are currently covering the stock, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $15.71.
SBRA has been the topic of several recent analyst reports. Scotiabank increased their price objective on Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 15th. Wedbush reaffirmed an “outperform” rating and set a $17.00 price target on shares of Sabra Health Care REIT in a report on Thursday, February 29th.
View Our Latest Research Report on SBRA
Insider Activity at Sabra Health Care REIT
Institutional Trading of Sabra Health Care REIT
Several hedge funds have recently bought and sold shares of the stock. JPMorgan Chase & Co. increased its stake in shares of Sabra Health Care REIT by 709.0% in the third quarter. JPMorgan Chase & Co. now owns 13,504,420 shares of the real estate investment trust’s stock worth $188,252,000 after purchasing an additional 11,835,109 shares in the last quarter. Norges Bank purchased a new stake in Sabra Health Care REIT in the 4th quarter worth $31,605,000. Vanguard Group Inc. raised its holdings in Sabra Health Care REIT by 2.5% during the first quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust’s stock valued at $516,545,000 after acquiring an additional 838,654 shares during the period. Duff & Phelps Investment Management Co. lifted its position in shares of Sabra Health Care REIT by 58.8% in the fourth quarter. Duff & Phelps Investment Management Co. now owns 2,101,595 shares of the real estate investment trust’s stock valued at $29,990,000 after acquiring an additional 778,355 shares in the last quarter. Finally, APG Asset Management US Inc. boosted its stake in shares of Sabra Health Care REIT by 91.7% in the fourth quarter. APG Asset Management US Inc. now owns 1,592,962 shares of the real estate investment trust’s stock worth $22,732,000 after acquiring an additional 762,002 shares during the period. Institutional investors own 99.40% of the company’s stock.
Sabra Health Care REIT Stock Performance
Shares of SBRA opened at $14.64 on Friday. The company has a market cap of $3.39 billion, a price-to-earnings ratio of 73.20, a P/E/G ratio of 2.31 and a beta of 1.22. The business’s fifty day simple moving average is $14.23 and its two-hundred day simple moving average is $14.08. Sabra Health Care REIT has a 12 month low of $11.36 and a 12 month high of $14.92. The company has a current ratio of 4.33, a quick ratio of 4.33 and a debt-to-equity ratio of 0.89.
Sabra Health Care REIT Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 31st. Stockholders of record on Monday, May 20th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 8.20%. The ex-dividend date of this dividend was Friday, May 17th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 600.00%.
Sabra Health Care REIT Company Profile
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
See Also
- Five stocks we like better than Sabra Health Care REIT
- What Are Dividend Contenders? Investing in Dividend Contenders
- Sarepta Therapeutics Stock Soars on FDA Approval
- Compound Interest and Why It Matters When Investing
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- Do ETFs Pay Dividends? What You Need to Know
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.